Foundersuite
Series A in 2024
Foundersuite provides software solutions tailored for startup entrepreneurs. Its platform offers tools for corporate housekeeping, finance, hiring, planning, investor relations, and progress tracking. Key features include Idea Validation modules, Startup Docs, Investor CRM, Progress Tracker, Company Tracker, and Media CRM. Founded in 2012, the company is headquartered in San Francisco.
Cypris
Venture Round in 2024
Founded in 2019, Cypris centralizes and analyzes technology-driven research on a user-friendly platform. It provides AI-powered insights from diverse datasets to accelerate R&D strategy for innovation teams.
Founded in 2019, Cypris centralizes and analyzes technology-driven research on a user-friendly platform. It provides AI-powered insights from diverse datasets to accelerate R&D strategy for innovation teams.
Instant Teams
Series A in 2022
Instant Teams is a technology-enabled company based in Rehoboth Beach, Delaware, specializing in providing remote workforce solutions. Founded in 2016, the company offers Arti, a platform that helps hiring managers define talent needs and matches pre-qualified, native English-speaking team members to projects. Instant Teams focuses on building high-quality customer support and operational teams, with a particular emphasis on military spouses and underserved talent communities, enabling 24/7 global support. The company's management platform handles payroll, compliance, time tracking, and reporting, making it a comprehensive solution for scaling and managing support operations. Notable customers include Walmart, Amazon, CrowdStrike, Assurance, and SeeSaw.
Peptilogics
Series A in 2017
Peptilogics, Inc. is a clinical-stage biotechnology company based in West Mifflin, Pennsylvania, founded in 2013. The company specializes in designing and developing novel peptide therapeutics aimed at addressing the urgent challenge of multidrug-resistant bacterial infections. Peptilogics utilizes a unique computational platform that enhances drug discovery by exploring new chemical design spaces while ensuring the biological viability and manufacturability of potential therapeutics. Their lead candidate, PLG0206, is a broad-spectrum anti-infective peptide that targets prosthetic joint infections and has received both FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation. Through its innovative eCAP (engineered cationic antibiotic peptide) platform, Peptilogics aims to provide effective treatment options against resistant bacteria and biofilms, ultimately improving patient outcomes and affordability in healthcare.
Iteros is an energy software company that specializes in modeling, controlling, and managing sustainable energy systems. The company offers an end-to-end software platform designed to optimize distributed generation, energy storage, and other complementary distributed energy resource technologies. Its platform features modules for modeling and simulation, monitoring and visualization, and control and management. By leveraging proprietary code, Iteros enables customers to simulate the performance of energy assets, leading to more reliable and sustainable energy grids. This capability allows energy businesses to optimize the operation of their resources and ecosystems, ultimately reducing costs and maximizing returns on investment.
ALung Technologies, Inc., established in 1997 and based in Pittsburgh, Pennsylvania, specializes in developing and manufacturing medical devices for treating acute respiratory failure. The company's primary product is the Hemolung Respiratory Assist System, a dialysis-like device that removes carbon dioxide and delivers oxygen directly to the blood, allowing patients' lungs to rest and heal while avoiding intubation and facilitating protective ventilation.